EGUDIN Report - Department of Urology, Thong Nhat Hospital

On the morning of September 26, 2019, at the Scientific Activities meeting of the Department of Urology of Thong Nhat Hospital, Medbolide Joint Stock Company had a report introducing the product EGUDIN (Solifenacin 10mg). The report meeting gathered 30 Doctors from the Faculty to attend.

At the event, Dr. Nguyen Van Quang - Deputy Head of the Department of Urology gave an overview of "Updated guidelines for diagnosis and treatment of OAB overactive bladder syndrome". Next, the representative of Medbolide Company reported more in-depth on clinical studies on the effectiveness and safety of the active ingredient Solifenacin compared to other active ingredients in the same group of anti-muscarinic bladder relaxants, and introduced the product Egudin same competitive advantage compared to other products on the market. The discussion topic received the attention of attending doctors.

At the end of the report, the representative of Medbolide Company thanked the Doctors, and hoped that Medbolide Company and Goclio products could continue to accompany Doctors in choosing the treatment of Bladder Syndrome. active for Patients.